Stereotaxis Unveils New Magnetic Robotic Cardiac Navigation System

Stereotaxis, a company that has developed robotic magnetic navigation technology to deliver catheters to the heart during ablation procedures, is introducing its latest generation system. The new Stereotaxis Genesis RMN platform features smaller magnets that can rotate around their center of mass, and which are positioned inside robotic arms that can move in a very controlled fashion, guiding a tip of a catheter precisely to the source of a cardiac arrhythmia.

The system is really designed to be used with the new Stereotaxis Imaging Model S, a package consisting of a single-plane high-energy X-ray C-arm, accompanying motorized table, and a boom with a monitor attached. It was designed with Omega Medical Imaging, a Sanford, Florida firm, and is meant to be well integrated with the Genesis RMN system for quick procedures, reduced radiation exposure, while delivering high-end imaging to make sure of positive outcomes.

The complete offering is considerably smaller and less intimidating looking than previous Stereotaxis systems, allowing for more room in the treatment room for clinicians and letting patients be a bit more at ease.

“It is very exciting and gratifying that we can improve clinical performance, as well as improve physician and patient experiences, while reducing cost. I want to thank the many Stereotaxis team members and external suppliers that made Genesis a reality. We are delighted to collaborate with Omega Medical Imaging and I want to thank them for making the vision of a complete robotic electrophysiology lab a reality,” in a published statement said David Fischel, Chairman and CEO of Stereotaxis.

Via: Stereotaxis…

Flashbacks: STOPping-Ventricular Tachycardia with Stereotaxis Ablation: Interview with Electrophysiologist Dr. Zyad Younan…; Stereotaxis Zaps Atrial Fibrillation All Right…

Source link

Related posts

Services Affected by Rural Hospitals Joining Health Systems


No Sign of Vertical Transmission of COVID-19 Found in Late Pregnancy


CHOP Research Team Redefines the Footprint of Viral Vector Gene Therapy


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy